Immunic
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Immunic generated cash of -$70,828,000, which is less than the previous year. Cash used in financing activities reached the amount of $1,033,000 last year. Net change in cash is therefore -$60,071,000.
Cash Flow
| 2014 | -40.82M | -2.04M | 106.91M |
|---|---|---|---|
| 2015 | -49.95M | -1.28M | 32.42M |
| 2016 | -35.77M | -21K | 12.37M |
| 2017 | -40.39M | -678K | 37.98M |
| 2018 | -43.16M | -415K | 4K |
| 2019 | -28.54M | 10.53M | 34.89M |
| 2020 | -46.12M | -146K | 144.43M |
| 2021 | -83.23M | -67K | 42.84K |
| 2022 | -65.14M | -9.74M | 95.76K |
| 2023 | -70.82M | 9.46M | 1.03M |
IMUX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 106.74M | 86.86M | 127.45M | 29.36M | 13.07M | 56.90M | 59.99M | 83.41M | 102.23M | 38.18M |
Operating activities | ||||||||||
Net income | -93.61M | -120.40M | -92.94M | -44.01M | -34.93M | -41.47M | -52.07M | -40.96M | -52.02M | -47.66M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 111K | 77K | 85K | 39K | 50K | 727K | 998K | 1.80M | 1.32M | 1.08M |
Stock-based compensation expense | 7.10M | 7.92M | 5.94M | 2.74M | 6.51M | 3.73M | 5.48M | 4.67M | 4.02M | 2.51M |
| Deferred income tax benefit | 7.10M | 7.92M | 5.94M | 2.74M | 6.51M | 3.73M | 5.48M | 4.67M | 4.02M | 2.51M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 817K | 799K | 176K | 1M | -462K | -770K | 287K | -459K | 281K | 46K |
Cash generated by operating activities | -70.82M | -65.14M | -83.23M | -46.12M | -28.54M | -43.16M | -40.39M | -35.77M | -49.95M | -40.82M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -9.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -334K | -112K | -67K | -146K | -55K | -597K | -685K | -556K | -2.34M | -1.40M |
Acquisitions Net | 0 | 0 | 0 | 0 | 10.66M | 0 | 7K | 0 | 0 | 0 |
Cash generated by investing activities | 9.46M | -9.74M | -67K | -146K | 10.53M | -415K | -678K | -21K | -1.28M | -2.04M |
Financing activities | ||||||||||
Common Stock Issued | 853K | 39.58M | 42.84M | 144.43M | 35.16M | 115K | 37.99M | 12.35M | 32.18M | 87.89M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 1.03M | 95.76K | 42.84K | 144.43M | 34.89M | 4K | 37.98M | 12.37M | 32.42M | 106.91M |
Net Change In Cash | -60.07M | 19.88M | -40.58M | 98.08M | 16.29M | -43.57M | -3.09M | -23.42M | -18.82M | 64.05M |
Cash at end of period | 46.67M | 106.74M | 86.86M | 127.45M | 29.36M | 13.32M | 56.90M | 59.99M | 83.41M | 102.23M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |